Compounds > perillyl alcohol
Page last updated: 2024-08-21

perillyl alcohol and Hyperplasia

perillyl alcohol has been researched along with Hyperplasia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alam, MS; Athar, M; Chaudhary, SC; Siddiqui, MS1
Barber, L; Davies, MG; Fulton, GJ; Hagen, PO; Svendsen, E1
Imagawa, DK; Si, MS1

Other Studies

3 other study(ies) available for perillyl alcohol and Hyperplasia

ArticleYear
Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis.
    Chemico-biological interactions, 2009, May-15, Volume: 179, Issue:2-3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Disease Models, Animal; Drug Screening Assays, Antitumor; Edema; Extracellular Signal-Regulated MAP Kinases; Female; Hyperplasia; Inflammation; Mice; Monoterpenes; Oxidative Stress; ras Proteins; Signal Transduction; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Time Factors

2009
Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    The Journal of surgical research, 1997, Volume: 69, Issue:1

    Topics: Administration, Oral; Animals; Carotid Artery, Common; Cell Division; Collagen; Hyperplasia; Jugular Veins; Monoterpenes; Rabbits; Terpenes; Thymidine; Tunica Intima; Vasoconstriction

1997
Prenylation inhibitors to treat proliferative renal disease.
    Lancet (London, England), 2000, Apr-22, Volume: 355, Issue:9213

    Topics: Animals; Drug Evaluation, Preclinical; Graft Rejection; Hyperplasia; Immunosuppressive Agents; Kidney Diseases; Lymphocyte Activation; Monoterpenes; Pravastatin; Protein Prenylation; Rats; T-Lymphocytes; Terpenes

2000